hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06260150, orgStudyIdInfo id: ZXT, briefTitle: Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients., statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-04-01, primaryCompletionDateStruct date: 2024-04, completionDateStruct date: 2024-04, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: Feng Tian, class: OTHER_GOV, descriptionModule briefSummary: The goal of this clinical trial is to evaluate the effectiveness of intraoperative intermittent pneumatic compression (IPC) device usage in preventing lower extremity deep vein thrombosis (DVT) in patients undergoing gastrointestinal surgery.The main question it aims to answer is provide a reference basis for determining the efficacy of IPC application during gastrointestinal surgery for preventing lower extremity DVT in patients.Participants are patients who require gastrointestinal surgery, specifically for the resection of gastrointestinal tumors. They will be divided into a control group and an experimental group. The experimental group will use an Intermittent Pneumatic Compression (IPC) device during surgery, while the control group will receive standard treatment. The objective is to observe whether the use of IPC during surgery can prevent the formation of Deep Vein Thrombosis (DVT) or lower the Risk of DVT., conditionsModule conditions: Gastrointestinal Neoplasms, conditions: Stomach Neoplasms, conditions: Intestinal Neoplasms, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Intermittent Pneumatic Compression Devices, outcomesModule primaryOutcomes measure: Incidence rate of DVT, secondaryOutcomes measure: Length of surgery, secondaryOutcomes measure: Intraoperative body temperature, secondaryOutcomes measure: Amount of bleeding during surgery, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Shandong Provincial Hospital, city: Jinan, state: Shandong, zip: 250021, country: China, geoPoint lat: 36.66833, lon: 116.99722, hasResults: False
protocolSection identificationModule nctId: NCT06260137, orgStudyIdInfo id: UludagThorax, briefTitle: Comparison of Two Different Methods for Reducing Pain After Lung Surgery, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-07-10, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-08, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: Uludag University, class: OTHER, descriptionModule briefSummary: The goal of this clinical study is to compare the effectiveness of the Rhomboid Intercostal Block and Sub-Servitus plan block and the effectiveness of the Rhomboid intercostal block in patients with video-supported thoracoscopic surgery. The main question it aims to answer is:Which of these two blocks more effectively reduces the patients' pain?, conditionsModule conditions: Postoperative Analgesia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Rhomboid intercostal block, interventions name: Rhomboid intercostal and subserratus plane block, outcomesModule primaryOutcomes measure: Postoperative analgesia, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hastane, city: Bursa, zip: 16210, country: Turkey, geoPoint lat: 40.19559, lon: 29.06013, hasResults: False
protocolSection identificationModule nctId: NCT06260098, orgStudyIdInfo id: H23-0617, briefTitle: StressLess Yoga Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-03, primaryCompletionDateStruct date: 2024-05-30, completionDateStruct date: 2024-05-30, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: University of Connecticut, class: OTHER, descriptionModule briefSummary: The purpose of this study is to assess the feasibility and acceptability of using an asynchronous online yoga program to reduce stress. The study will use an 8 week asynchronous yoga intervention of two different types of yoga (high in breath work and meditation; low in vigorous movement/postures vs. low breath work and meditation; high movement/postures). In addition to self-report stress, measures include sleep, heart rate variability, mindfulness, Essential Properties of Yoga, and acceptability questions., conditionsModule conditions: Stress, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Yoga with High Breath work & meditation; Low movement/postures, interventions name: Yoga with Low Breath work & meditation; High movement/postures, outcomesModule primaryOutcomes measure: The number (percentage)of people completing the whole protocol (6/8 yoga classes & 2 in-person visits), primaryOutcomes measure: The combined score (out of 35) on the 5-item Treatment Acceptability Questionnaire (TAQ), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bousfield Psychology Building, 406 Babbidge Road, status: RECRUITING, city: Storrs, state: Connecticut, zip: 06269, country: United States, contacts name: Crystal Park, PhD, role: CONTACT, phone: 860-486-3520, email: crystal.park@uconn.edu, contacts name: Crystal Park, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.80843, lon: -72.24952, hasResults: False
protocolSection identificationModule nctId: NCT06260085, orgStudyIdInfo id: 686, briefTitle: Effect of Listening to Relatives' Voice Recordings on Chest Pain, Anxiety, and Depression in Coronary ICU Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-04, primaryCompletionDateStruct date: 2023-07-04, completionDateStruct date: 2023-09-04, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: T.C. ORDU ÜNİVERSİTESİ, class: OTHER, descriptionModule briefSummary: The aim of the study was to evaluate the effect of listening to the voice recordings of relatives of patients with acute myocardial infarction (AMI) who were treated in the coronary intensive care unit on chest pain, anxiety and depression parameters of the patients.Methods In the study, which was conducted as a randomised, controlled, experimental study, voice recordings of the family members of the patients were created and played to the patients through a music pillow. The study was carried out with 60 patients, 30 experimental and 30 control groups. Three tests were applied to the patients 15 minutes before, 15 and 30 minutes after the application. The data of the study were collected using the "Patient Introduction Form", "Hospital Anxiety Depression Scale", "Visual Analogue Scale" and "Patient Follow-up Form"., conditionsModule conditions: Acute Myocardial Infarction, conditions: Intensive Care Unit Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: The clinical nurse collected the data, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Relatives vioce record, outcomesModule primaryOutcomes measure: Chest Pain, secondaryOutcomes measure: Anxiety, and Depression, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yasemin Kalkan Uğurlu, city: Ordu, zip: 52200, country: Turkey, geoPoint lat: 40.97782, lon: 37.89047, hasResults: False
protocolSection identificationModule nctId: NCT06260072, orgStudyIdInfo id: IRB-HSR 21920, briefTitle: Magnesium and Riboflavin Treatment for Post-Concussion Headache, statusModule overallStatus: RECRUITING, startDateStruct date: 2020-02-10, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: University of Virginia, class: OTHER, descriptionModule briefSummary: This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person., conditionsModule conditions: Concussion, Intermediate, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 108, type: ESTIMATED, armsInterventionsModule interventions name: magnesium and riboflavin supplement, outcomesModule primaryOutcomes measure: Headache Intensity and Duration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Virginia Student Health and Wellness Center, status: RECRUITING, city: Charlottesville, state: Virginia, zip: 22903, country: United States, contacts name: Karen Ahern, BSN MBA, role: CONTACT, phone: 434-924-1549, email: kaa7p@virginia.edu, geoPoint lat: 38.02931, lon: -78.47668, hasResults: False
protocolSection identificationModule nctId: NCT06260059, orgStudyIdInfo id: STUDY23070148, secondaryIdInfos id: Pitt2024, type: OTHER_GRANT, domain: Pittsburgh Foundation, briefTitle: Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease, acronym: EmpaCHD, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02, primaryCompletionDateStruct date: 2026-12-31, completionDateStruct date: 2027-06-01, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: Anita Saraf, class: OTHER, collaborators name: The Pittsburgh Foundation, descriptionModule briefSummary: The goal of the study is to investigate the feasibility and benefit of novel guideline-directed heart failure therapy drug Empagliflozin (Jardiance) for adult patients with congenital heart disease (ACHD)., conditionsModule conditions: Adult Congenital Heart Disease, conditions: Heart Failure, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Group 1: Empagliflozin 10 MG daily Group 2: Placebo, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Empagliflozin 10 MG, interventions name: Placebo, outcomesModule primaryOutcomes measure: Change in Ejection fraction (EF), primaryOutcomes measure: Change in Myocardial characteristics (T1 mapping of cMRI), primaryOutcomes measure: Change in Myocardial characteristics (Global strain on MRI), primaryOutcomes measure: Change in Myocardial characteristics (Global strain on echocardiogram), primaryOutcomes measure: Change in functional exercise capacity of participants., primaryOutcomes measure: Number of Participants Hospitalized for Cardiac Reasons or heart transplantation, primaryOutcomes measure: Number of Deaths, secondaryOutcomes measure: Change in inflammatory serum biomarkers, secondaryOutcomes measure: Change in functional Neuropsychological Testing, secondaryOutcomes measure: Change in New York Heart Association (NYHA) Class, secondaryOutcomes measure: Change Patient-Reported Outcomes Measurement Information System (PROMIS), secondaryOutcomes measure: Change in Kansas City Cardiomyopathy (KCCQ), secondaryOutcomes measure: Change in Neuro-QOL, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Magee Women's Hospital, city: Pittsburgh, state: Pennsylvania, zip: 15213, country: United States, geoPoint lat: 40.44062, lon: -79.99589, locations facility: Presbyterian Hospital, city: Pittsburgh, state: Pennsylvania, zip: 15213, country: United States, geoPoint lat: 40.44062, lon: -79.99589, locations facility: Children's Hospital of Pittsburgh, city: Pittsburgh, state: Pennsylvania, zip: 15224, country: United States, geoPoint lat: 40.44062, lon: -79.99589, hasResults: False
protocolSection identificationModule nctId: NCT06260046, orgStudyIdInfo id: Robot Nx-SFTN, briefTitle: Effect of Sufentanil on the Postoperative Pain, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-01-15, completionDateStruct date: 2027-01-15, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: Seoul National University Hospital, class: OTHER, descriptionModule briefSummary: This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery., conditionsModule conditions: Postoperative Pain, Acute, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 48, type: ESTIMATED, armsInterventionsModule interventions name: Sufentanil, interventions name: Remifentanil, outcomesModule primaryOutcomes measure: opioid consumption, secondaryOutcomes measure: Richmond Agitation-Sedation scale, secondaryOutcomes measure: Incidence of postoperative nausea and vomiting, secondaryOutcomes measure: Number of patients who administered antiemetics, secondaryOutcomes measure: Pain score, eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Seoul National University Bundang Hospital, city: Seongnam, country: Korea, Republic of, contacts name: Chang-Hoon Koo, role: CONTACT, email: vollock9@gmail.com, geoPoint lat: 37.43861, lon: 127.13778, hasResults: False